Bluejay Diagnostics Inc BJDX

$0.84 -0.01 (-1.12%)

Valuation

Market cap
3,738,000
Revenue TTM
$0
Net income TTM
$-6,850,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
114,800
Avg volume
3,871,554
Day's range
$0.83 – $0.85
Shares out
4,468,000
Stochastic %K
3%
Beta
0.89
Analysts
Strong Buy
Price target
$32.00

Price

Company profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using...

Show more

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Industry
Medical Devices
Sector
Healthcare
Phone
844 327 7078
Website
https://bluejaydx.com
Address
360 Massachusetts Avenue, Suite 203, Acton, United States

Latest news

No headlines yet.